Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
61 hedge funds and large institutions have $11M invested in Mural Oncology in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 19 closing their positions.
149% more call options, than puts
Call options by funds: $1.94M | Put options by funds: $776K
8% less funds holding
Funds holding: 66 → 61 (-5)
16.96% less ownership
Funds ownership: 47.68% → 30.72% (-17%)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
46% less capital invested
Capital invested by funds: $20.3M → $11M (-$9.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$1.1M |
| 2 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$556K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$400K |
| 4 |
DAM
Deltec Asset Management
New York
|
+$385K |
| 5 |
TC
Torno Capital
Cohasset,
Massachusetts
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.27M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$2.22M |
| 3 |
ACA
Acorn Capital Advisors
New York
|
-$1.61M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$1.07M |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$865K |
MURA Hedge Fund Activity: Q3 2025 in Review
61 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q3 2025, worth a combined $11M — down 46% from $20.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of MURA and 14 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 13 added.
The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $1.1M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $3.27M sold.
- 61 institutional investors held Mural Oncology (MURA) as of Q3 2025, down from 66 in Q2 2025.
- Funds reported $11M of Mural Oncology stock for Q3 2025, down 46% quarter-over-quarter.
- 14 funds opened new Mural Oncology positions in Q3 2025 and 19 closed out, a net change of -5 holders.
- The largest Mural Oncology buyer in Q3 2025 was OMERS Administration Corp, an estimated $1.1M added.
- The largest Mural Oncology seller in Q3 2025 was Soleus Capital Management, an estimated $3.27M sold.
Based on aggregated 13F filings for Q3 2025.